Market Cap 2.16M
Revenue (ttm) 170,000.00
Net Income (ttm) -17.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,188.24%
Debt to Equity Ratio 0.00
Volume 136,000
Avg Vol 169,141
Day's Range N/A - N/A
Shares Out 764,000.00
Stochastic %K 0%
Beta 0.89
Analysts Sell
Price Target $150.00

Company Profile

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 352 448 7797
Fax: 352 480 4620
Address:
2117 SW Highway 484, Ocala, United States
ultimatebastos
ultimatebastos Aug. 3 at 5:23 PM
$AIM my treatment now costs nearly $ 20,000 a month. Luckely i got good insurance I would not do it otherwhise. There is a market for Ampligen and i’d probably be better of with Ampligen.
0 · Reply
TheLionofwallstreet
TheLionofwallstreet Aug. 2 at 8:01 PM
$AIM damn i could double my shares rn for penuts compared to my avg... I might just have to.
3 · Reply
ultimatebastos
ultimatebastos Aug. 2 at 7:18 PM
$AIM naked shorting so clear what the criminal tradingalgo has done. Really hope the company Will take action now finally.
0 · Reply
XQuise
XQuise Aug. 2 at 4:01 PM
1 · Reply
h2oMark
h2oMark Aug. 2 at 4:05 AM
$AIM To all of the newbies here, I've been in AIM for over 5 years. You're buying at $3 ish, hoping for $8 - 9 ish. If you're buying now, chances are good that you will see a decent ROI. Yes, Ampligen works. Why there's been no licensing deal, or sale of the company, is a mystery. We're all befuddled. After averaging down for the last 5 yrs, I've finally dropped my overall average to just under $100/share (woohoo!) Every time there is positive clinical data released, the sp drops ~ 15%. It defies logic, but that's the reality. Yes, the sp will bounce up & down some, & a few of you might actually be profitable. But, in my opinion, there won't be any significant price movement until the company is sold, or there are licensing deal(s). By "significant," I mean 25x - 1000x the current sp. If .................. ? When ........... ? (cont'd)
1 · Reply
funnymoney90210
funnymoney90210 Aug. 1 at 11:20 PM
$AIM come on $124 😂
1 · Reply
All4thedough
All4thedough Aug. 1 at 10:48 PM
$AIM More. Down.
1 · Reply
longzone
longzone Aug. 1 at 9:56 PM
$AIM The well-received secondary stock or convertible note offering is an especially strong buy signal for certain small-cap stocks and early-stage growth stocks. That’s because it signals huge demand for a stock that still has a relatively small public float and/or is growing rapidly.
1 · Reply
longzone
longzone Aug. 1 at 9:20 PM
$AIM next week will be insane
0 · Reply
rayk1
rayk1 Aug. 1 at 7:07 PM
$AIM new ATL!!!! Congrats Equels! Please resign as AIM‘s CEO!!! Loyal shareholders lost all their money,good job👍🙌👎
1 · Reply
Latest News on AIM
Why Is Micro-Cap AIM ImmunoTech Stock Surging?

Jul 28, 2025, 11:12 AM EDT - 6 days ago

Why Is Micro-Cap AIM ImmunoTech Stock Surging?


AIM ImmunoTech Resumes Trading on NYSE American

Jun 17, 2025, 8:55 AM EDT - 6 weeks ago

AIM ImmunoTech Resumes Trading on NYSE American


AIM ImmunoTech Announces 1-for-100 Reverse Stock Split

Jun 11, 2025, 4:15 PM EDT - 7 weeks ago

AIM ImmunoTech Announces 1-for-100 Reverse Stock Split


Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript

May 13, 2025, 9:54 AM EDT - 2 months ago

Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript


AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 9:19 AM EDT - 4 months ago

AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call Transcript


Aimia Inc. (AIMFF) Q4 2024 Earnings Call Transcript

Mar 28, 2025, 11:39 AM EDT - 4 months ago

Aimia Inc. (AIMFF) Q4 2024 Earnings Call Transcript


AIM's Clinical Strategy Under Incumbent Board Has Totally Failed

Dec 11, 2024, 7:30 AM EST - 8 months ago

AIM's Clinical Strategy Under Incumbent Board Has Totally Failed


AIM ImmunoTech Announces Cash Conservation Plan

Nov 27, 2024, 8:00 AM EST - 8 months ago

AIM ImmunoTech Announces Cash Conservation Plan


AIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 10:32 AM EST - 9 months ago

AIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call Transcript


Aimia Inc. (AIMFF) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 1:04 PM EST - 9 months ago

Aimia Inc. (AIMFF) Q3 2024 Earnings Call Transcript


ultimatebastos
ultimatebastos Aug. 3 at 5:23 PM
$AIM my treatment now costs nearly $ 20,000 a month. Luckely i got good insurance I would not do it otherwhise. There is a market for Ampligen and i’d probably be better of with Ampligen.
0 · Reply
TheLionofwallstreet
TheLionofwallstreet Aug. 2 at 8:01 PM
$AIM damn i could double my shares rn for penuts compared to my avg... I might just have to.
3 · Reply
ultimatebastos
ultimatebastos Aug. 2 at 7:18 PM
$AIM naked shorting so clear what the criminal tradingalgo has done. Really hope the company Will take action now finally.
0 · Reply
XQuise
XQuise Aug. 2 at 4:01 PM
1 · Reply
h2oMark
h2oMark Aug. 2 at 4:05 AM
$AIM To all of the newbies here, I've been in AIM for over 5 years. You're buying at $3 ish, hoping for $8 - 9 ish. If you're buying now, chances are good that you will see a decent ROI. Yes, Ampligen works. Why there's been no licensing deal, or sale of the company, is a mystery. We're all befuddled. After averaging down for the last 5 yrs, I've finally dropped my overall average to just under $100/share (woohoo!) Every time there is positive clinical data released, the sp drops ~ 15%. It defies logic, but that's the reality. Yes, the sp will bounce up & down some, & a few of you might actually be profitable. But, in my opinion, there won't be any significant price movement until the company is sold, or there are licensing deal(s). By "significant," I mean 25x - 1000x the current sp. If .................. ? When ........... ? (cont'd)
1 · Reply
funnymoney90210
funnymoney90210 Aug. 1 at 11:20 PM
$AIM come on $124 😂
1 · Reply
All4thedough
All4thedough Aug. 1 at 10:48 PM
$AIM More. Down.
1 · Reply
longzone
longzone Aug. 1 at 9:56 PM
$AIM The well-received secondary stock or convertible note offering is an especially strong buy signal for certain small-cap stocks and early-stage growth stocks. That’s because it signals huge demand for a stock that still has a relatively small public float and/or is growing rapidly.
1 · Reply
longzone
longzone Aug. 1 at 9:20 PM
$AIM next week will be insane
0 · Reply
rayk1
rayk1 Aug. 1 at 7:07 PM
$AIM new ATL!!!! Congrats Equels! Please resign as AIM‘s CEO!!! Loyal shareholders lost all their money,good job👍🙌👎
1 · Reply
Pitbull28
Pitbull28 Aug. 1 at 5:29 PM
$AIM Following up on my previous post, I personally will continue to buy-and-hold my position, even if it takes another year or more.
0 · Reply
Pitbull28
Pitbull28 Aug. 1 at 5:24 PM
$AIM Having been involved in this for many years, the current situation presents no anomalies. The strategy remains to maintain a long position. While the previous ascent to 39 was favorable, it did not fully satisfy the expectations of us long-term investors. With the successful completion of Phase 2, we have to stay optimistic about future developments.
1 · Reply
longzone
longzone Aug. 1 at 5:09 PM
$AIM no reason for people to sell here. So other to buy to push this up
0 · Reply
acesofrace
acesofrace Aug. 1 at 3:40 PM
$AIM offering closed
1 · Reply
acesofrace
acesofrace Aug. 1 at 3:37 PM
$AIM shaping up
0 · Reply
longzone
longzone Aug. 1 at 2:24 PM
$AIM this can gap up any day
0 · Reply
WallStreetIsNotEasy
WallStreetIsNotEasy Aug. 1 at 2:01 PM
$AIM Everything is going to work out here but it won’t be until late this year 👌
1 · Reply
longzone
longzone Aug. 1 at 1:49 PM
$AIM $7 is my price target
0 · Reply
crown88
crown88 Aug. 1 at 1:28 PM
0 · Reply
jonjonson1234
jonjonson1234 Aug. 1 at 12:38 PM
$AIM When do we think that the company will see delisting warnings again? When the share price goes below $1.00? Or will they have leeway down to $0.10?
2 · Reply
ultimatebastos
ultimatebastos Aug. 1 at 7:19 AM
$AIM kim il yung is a parasite living on the backs of the people he represses as Slaves.
1 · Reply
ultimatebastos
ultimatebastos Aug. 1 at 7:17 AM
$AIM $BE robbing people is illegal robbing people by naked shorting is illegal. On top of that many of those market manipulators are puppets from rogue States and they generate a constant stream of funds to sabotage the west. What’s healthy in destroying perfectly good companies.
0 · Reply